Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ESMC NASDAQ:HSCS NASDAQ:SINT NASDAQ:SSKN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESMCEscalon Medical$0.28-4.1%$0.33$0.11▼$0.46$2.06M0.433,472 shs12,800 shsHSCSHeartSciences$3.41+0.3%$3.74$2.36▼$6.47$7.74M2.56111,258 shs7,670 shsSINTSintx Technologies$4.15-2.1%$3.08$1.71▼$8.60$11.70M0.6583,994 shs172,495 shsSSKNStrata Skin Sciences$2.38+17.2%$2.09$1.61▼$3.79$8.47M0.66149,712 shs4.44 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESMCEscalon Medical0.00%+2.96%-13.45%-39.33%+97.30%HSCSHeartSciences+0.29%-6.58%+2.40%-5.83%+6.23%SINTSintx Technologies-2.12%+18.91%+60.85%+50.36%+21.35%SSKNStrata Skin Sciences+17.24%+34.46%+21.68%-3.68%-31.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationESMCEscalon MedicalN/AN/AN/AN/AN/AN/AN/AN/AHSCSHeartSciences3.3247 of 5 stars3.55.00.00.03.80.80.6SINTSintx Technologies2.9172 of 5 stars3.54.00.00.03.61.70.0SSKNStrata Skin Sciences2.8523 of 5 stars3.53.00.00.03.11.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceESMCEscalon Medical 0.00N/AN/AN/AHSCSHeartSciences 3.00Buy$13.00281.23% UpsideSINTSintx Technologies 3.00Buy$28.00574.70% UpsideSSKNStrata Skin Sciences 3.00Buy$6.00152.10% UpsideCurrent Analyst Ratings BreakdownLatest ESMC, SINT, HSCS, and SSKN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2025SINTSintx TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$30.00 ➝ $28.00(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookESMCEscalon Medical$11.98M0.17$0.04 per share7.71N/A∞HSCSHeartSciencesN/AN/AN/AN/A$0.18 per shareN/ASINTSintx Technologies$2.89M3.96N/AN/A$1.45 per share2.86SSKNStrata Skin Sciences$33.56M0.30N/AN/A$0.07 per share34.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateESMCEscalon Medical-$130K$0.055.56∞N/A4.70%45.60%12.66%N/AHSCSHeartSciences-$8.77M-$9.36N/AN/AN/AN/A-293.60%-135.39%9/11/2025 (Estimated)SINTSintx Technologies-$11.02M-$50.56N/A∞N/A-674.05%-256.59%-121.32%11/11/2025 (Estimated)SSKNStrata Skin Sciences-$10.09M-$2.84N/AN/AN/A-35.13%-266.94%-32.66%11/12/2025 (Estimated)Latest ESMC, SINT, HSCS, and SSKN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/11/2025N/AHSCSHeartSciences-$2.41N/AN/AN/AN/AN/A8/14/2025Q2 2025SINTSintx Technologies-$0.79-$0.91-$0.12-$0.91$0.40 million$0.15 million8/13/2025Q2 2025SSKNStrata Skin Sciences-$0.27-$0.60-$0.33-$0.60$8.56 million$7.70 million7/24/2025Q4 2025HSCSHeartSciences-$2.51-$1.88+$0.63-$1.88N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthESMCEscalon MedicalN/AN/AN/AN/AN/AHSCSHeartSciencesN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/ASSKNStrata Skin SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioESMCEscalon Medical0.141.921.23HSCSHeartSciencesN/A0.590.41SINTSintx TechnologiesN/A2.572.41SSKNStrata Skin Sciences49.580.980.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipESMCEscalon MedicalN/AHSCSHeartSciences17.24%SINTSintx Technologies18.38%SSKNStrata Skin Sciences32.43%Insider OwnershipCompanyInsider OwnershipESMCEscalon Medical1.90%HSCSHeartSciences1.80%SINTSintx Technologies4.08%SSKNStrata Skin Sciences39.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableESMCEscalon Medical407.42 million7.27 millionNot OptionableHSCSHeartSciences102.28 million2.24 millionNot OptionableSINTSintx Technologies402.76 million2.65 millionNot OptionableSSKNStrata Skin Sciences1204.17 million2.54 millionNot OptionableESMC, SINT, HSCS, and SSKN HeadlinesRecent News About These CompaniesStrata Skin Sciences Faces Nasdaq Compliance NoticeAugust 22, 2025 | msn.comStrata Skin Sciences Unveils Strategic InitiativesAugust 18, 2025 | msn.comSTRATA Skin Sciences Eyes Growth from Expanded Reimbursement Despite Q2 Revenue DeclineAugust 16, 2025 | msn.comAnalysts Just Made A Major Revision To Their STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Revenue ForecastsAugust 16, 2025 | finance.yahoo.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q2 2025 Earnings Call TranscriptAugust 16, 2025 | msn.comSTRATA Skin Sciences Eyes Market GrowthAugust 14, 2025 | aol.comAStrata Skin Sciences signals threefold TAM expansion as CPT code changes unlock 30M patient marketAugust 14, 2025 | msn.comStrata Skin Sciences Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comSTRATA Skin Sciences, Inc. (SSKN) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comPreview: Strata Skin Sciences's EarningsAugust 12, 2025 | benzinga.comStrata Skin Sciences Inc (SSKN) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 12, 2025 | finance.yahoo.comSTRATA Skin Sciences Targets Early CMS Reimbursement for Expanded XTRAC Laser Use, Cites New Vitiligo Study and Legal VictoryAugust 9, 2025 | msn.comSTRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ PatientsAugust 7, 2025 | globenewswire.comSTRATA Skin Sciences to Announce Q2 2025 Results on August 13August 2, 2025 | msn.comSTRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate UpdateJuly 31, 2025 | globenewswire.comSTRATA Skin Sciences, Inc. (SSKN) - Yahoo FinanceJuly 18, 2025 | finance.yahoo.comStrata Skin Sciences (NASDAQ:SSKN) Stock, Short Interest ReportJuly 9, 2025 | benzinga.comStrata Skin Sciences Earnings Estimates, EPS & Revenue | NASDAQ:SSKN | BenzingaJuly 9, 2025 | benzinga.comSSKN STRATA Skin Sciences, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comSTRATA Skin Sciences Gains CPT Code Expansion For Excimer Laser Use In Skin Inflammatory DiseasesMay 21, 2025 | nasdaq.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeESMC, SINT, HSCS, and SSKN Company DescriptionsEscalon Medical OTCMKTS:ESMC$0.28 -0.01 (-4.14%) As of 08/28/2025 02:12 PM EasternEscalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.HeartSciences NASDAQ:HSCS$3.41 +0.01 (+0.29%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$3.30 -0.12 (-3.37%) As of 08/29/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Sintx Technologies NASDAQ:SINT$4.15 -0.09 (-2.12%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$4.28 +0.13 (+3.01%) As of 08/29/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.Strata Skin Sciences NASDAQ:SSKN$2.38 +0.35 (+17.24%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.43 +0.05 (+2.10%) As of 08/29/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It 3 Reasons Gartner Could Be the Best Buy of Q3 NIO Just Got Its Second Upgrade of the Month, and It’s Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
